IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 839.00K | 1.30M | 2.19M | 3.27M | 4.14M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 839.00K | 1.30M | 2.19M | 3.27M | 4.14M |
| Cost of Revenue | 1.68M | 1.61M | 2.32M | 3.23M | 3.91M |
| Gross Profit | -845.00K | -314.00K | -127.00K | 39.00K | 233.00K |
| SG&A Expenses | 8.80M | 9.88M | 11.61M | 13.05M | 14.31M |
| Depreciation & Amortization | 2.52M | 1.61M | 2.37M | 1.68M | 1.64M |
| Other Operating Expenses | 7.29M | 7.09M | 8.06M | 8.66M | 8.74M |
| Total Operating Expenses | 22.74M | 22.59M | 26.20M | 28.67M | 30.98M |
| Operating Income | -21.91M | -21.29M | -24.01M | -25.40M | -26.84M |
| Income Before Tax | -14.57M | -15.63M | -24.03M | -24.83M | -26.64M |
| Income Tax Expenses | -120.00K | 17.00K | 12.00K | -20.00K | -15.00K |
| Earnings from Continuing Operations | -14.45 | -15.65 | -24.04 | -24.81 | -26.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.45M | -15.65M | -24.04M | -24.81M | -26.63M |
| EBIT | -21.91M | -21.29M | -24.01M | -25.40M | -26.84M |
| EBITDA | -20.01M | -19.38M | -21.94M | -24.03M | -25.48M |
| EPS Basic | -0.05 | -0.06 | -0.09 | -0.09 | -0.10 |
| Normalized Basic EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.07 |
| EPS Diluted | -0.05 | -0.06 | -0.09 | -0.10 | -0.11 |
| Normalized Diluted EPS | -0.03 | -0.04 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 1.41B | 1.16B | 1.12B | 1.08B | 1.04B |
| Average Diluted Shares Outstanding | 1.42B | 1.17B | 1.13B | 1.09B | 1.04B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |